Adaptive Biotechnologies Corporation (ADPT)
NASDAQ·Healthcare·Biotechnology
$27.82
-0.89%
Mkt Cap $4.46B
Analyst Ratings
Buy
11
Hold
3
Sell
0
Price Target (13 analysts)
$21.25
Range $20.00 – $22.00
Implied Upside
-23.6%
Consensus $21.25 vs current $27.82